SWX:NOVNPharmaceuticals
A Look At Novartis (SWX:NOVN) Valuation After Cardiovascular Breakthroughs And Digital Health Partnership News
Novartis (SWX:NOVN) has moved into focus after a series of high profile developments, including a World Economic Forum cardiovascular partnership, fresh drug pipeline updates, and recent share price strength ahead of upcoming earnings.
See our latest analysis for Novartis.
Those developments have arrived as the share price trades near its year high at CHF116.52, with a 30 day share price return of 5.83% and a 1 year total shareholder return of 30.56%, which hints at firm momentum rather than...